Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of EGb761 on Brain Glucose Metabolism in Elderly
NCT00814346Phase 2Completed
- Sponsor
- Ipsen
- Start
- Oct 2008
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ginkgo biloba extract in Alzheimer's disease (AD), cognitive impairment, sponsored by Ipsen. Started Oct 2008; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
Alzheimer's disease (AD)cognitive impairment
Beyond the preview
Go deeper on NCT00814346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814346.